Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
about
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's diseaseTowards trans-diagnostic mechanisms in psychiatry: neurobehavioral profile of rats with a loss-of-function point mutation in the dopamine transporter gene.Behavioral phenotyping of mouse models of Parkinson's disease.5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain.MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 MouseAge- and duration-dependent effects of MPTP on cortical serotonin systemsExperimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Animal models of the non-motor features of Parkinson's disease.REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effectsTraumatic brain injury - modeling neuropsychiatric symptoms in rodents.Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.Beyond muscles: The untapped potential of creatine.Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats.Non-motor features of Parkinson disease.No effect of acute tryptophan depletion on verbal declarative memory in young persons with ADHD.Prosocial effects of prolactin in male rats: Social recognition, social approach and social learning.Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice.Hypothermia alleviates hypoxic ischemia-induced dopamine dysfunction and memory impairment in rats
P2860
Q26767268-E9EA6141-C356-405F-9444-0A5D36CD497FQ28394023-CB2CF935-C280-44D3-AA35-7B9A4235BA2CQ33588082-60AB6707-7EFE-45BA-BF3F-91429D0D47ABQ33820609-3BCF0C16-1A01-4AD2-B205-1CBF9E6D3C0EQ33886545-9B0A5B6D-27AA-4F2F-BAB3-450265D974D6Q33987540-6BCB5288-8924-4570-B7E9-B81ADE414D17Q34094065-BB626C57-F7DF-4EAB-81F9-AC70765EBF3EQ34307633-2C5A22A4-B622-45E9-BE4D-641DF595C99AQ35069025-0C7437B6-9985-4282-A0EB-09410E111D54Q35101285-23E2FFA2-68DA-40ED-A470-D17922337A7CQ35534830-7C5B71E2-F3E2-400B-87FB-3B4635909967Q35786658-70276B01-50AE-4644-AE7F-A71D29AAA105Q36200063-8F2FD068-483F-441E-A7DD-5DA0F15C5382Q36235578-B9472C23-CCB0-4031-8549-418C2D412443Q36903829-F5AD3E04-B801-4621-89D2-D22C1E148D0CQ37218200-6E6FB1F9-2A94-499F-AFEB-9F614693ADF9Q37396722-B1EEE2CD-1EC0-41FA-9F64-2305F720AE9AQ37771075-A24B5585-B7CE-45FF-AE4F-26C7CD9B65D3Q37973611-8DEFA42B-692C-4863-AD73-3D9C84F8FE09Q38700215-3069BCA2-7134-4955-8057-C2724BD7C489Q38747374-2227E580-F13D-4227-85A6-EAE882FE7323Q39358549-C1780962-CA31-4D60-849D-F164200FE922Q39465530-D6507B15-8D99-485E-8918-8AD0A1BDD62BQ46512810-410702F1-80C9-41E1-B373-D6571EDA8D87Q48078497-D8F5AF01-C950-4C02-8425-479EBCA9F55EQ48482169-1B38E305-455F-4B62-BBE4-DB083D2914B8Q48483209-29CFB029-B4DD-402E-8B04-002D8237F014Q52721898-CCB66020-3DB2-4BE1-9A0A-6380AAD2969DQ58168438-F7C7A484-697F-4287-8CC7-41120618DE7B
P2860
Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@ast
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@en
type
label
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@ast
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@en
prefLabel
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@ast
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@en
P2093
P2860
P921
P1476
Memory, mood, dopamine, and se ...... model of basal ganglia injury.
@en
P2093
Alexandra Smith
Avery Abernathy
Daniel M Togasaki
Daniel P Holschneider
Giselle M Petzinger
Marta G Vucković
Michael W Jakowec
Ruth I Wood
P2860
P304
P356
10.1016/J.NBD.2008.07.015
P577
2008-08-05T00:00:00Z